In a recent study examining the efficacy of CyberKnife® for the treatment of lung cancer metastases, researchers determined that patients may experience better local control and low toxicity.
The study results were drawn from a retrospective analysis of 95 patients with 134 lung metastases treated with CyberKnife stereotactic body radiation therapy (SBRT). This treatment method precisely targets tumors with high-dose radiation that is delivered in five or fewer treatments. The approach offers an important option for patients with recurring metastatic tumors who may require a nonsurgical treatment method. Read details of the study here.
Lung cancer is among the most common metastatic cancers. If diagnosed at a later stage, the cancer is likely to have spread, or metastasized. Common sites of lung cancer metastasis include the lymph nodes, the brain and bones.
At Columbus CyberKnife, lung cancer and metastatic tumors are frequently treated conditions. To learn more about how CyberKnife treats metastatic cancer, visit our Conditions Treated page.
This is not intended as medical advice to replace the expertise and judgment of your health care team. It is intended to help you and your family make informed decisions, together with your doctor.